Wikipedia

Draft:Altasciences

  • Comment: See WP:SOLUTIONS and WP:NPOV. Rewrite article in neutral & encyclopedic for tone & content. Cut out any content without a reliable, independent source. CopyleftEverything (talk) 03:37, 11 June 2026 (UTC)
Altasciences Company, Inc.
FormerlyAlgorithme Pharma
TypePrivate
Industry• Contract research organization
  • Contract manufacturing organization
Founded1995; 31 years ago
Headquarters575 Armand-Frappier Boulevard

Laval, Quebec H7V 4B3

Canada
Area served
Worldwide
Key people
• Marie-Hélène Raigneau (CEO)
  • Steve Mason (Co-Chief Operating Officer)
  • Robert Sabelli (Co-Chief Operating Officer)
  • Mariano Rodriguez (Executive Vice President and Chief Financial Officer)
Services• Nonclinical research
  • Clinical pharmacology
  • Bioanalysis
  • Drug formulation
  • Manufacturing
OwnerNovo Holdings A/S
Number of employees
~2,215.[1]
Websitewww.altasciences.com

Altasciences is an early‑phase contract research organization (CRO) and contract development and manufacturing organization (CDMO) incorporated in 1995, headquartered in Laval, Québec, Canada.[2][3][4] The company provides nonclinical safety testing, clinical pharmacology, bioanalysis, formulation, and manufacturing, and analytical services to pharmaceutical and biotechnology companies involved in drug development.[5] Altasciences operates nine facilities across Canada and the United States and maintains an office in the United Kingdom.[6]

History

edit

Altasciences originated as Algorithme Pharma, which was founded in 1992 to conduct clinical pharmacology studies. In 2013, following the integration of several research and development organizations, the company adopted the name Altasciences.

1992-2010, Founding and Early Years

edit

Algorithme Pharma was founded in 1992[7] with a clinical site and bioanalytical laboratory in Montréal, Québec. The company initially focused on clinical pharmacology and bioanalytical services for generic drug development. In 1995,[8] it was incorporated as a contract research organization by co-founder Marc Lefebvre.[9] In 2001, the company established its headquarters and bioanalytical laboratory in Laval, Quebec.

2010-2013, Rebranding

edit

In 2010, Chris Perkin was appointed Chief Executive Officer,[10] having previously held leadership positions at Charles River Laboratories, CTBR, and Beecham Pharmaceuticals.

During Perkin’s tenure as Chief Executive Officer, the company expanded its focus beyond generic drug development. In 2013, Algorithme Pharma rebranded as Altasciences Company, Inc. (“Altasciences”) and expanded its service offerings to include CRO and CDMO services.

2013-2023, Expansion

edit

In 2013, Altasciences acquired Vince & Associates, expanding its presence in the United States and adding clinical pharmacology services for investigational drug development programs. In 2018, the company acquired SNBL USA, adding nonclinical research to its scope of services.

During the 2020s, Altasciences completed a series of acquisitions. The acquisition of Alliance Contract Pharma in 2020 added contract manufacturing and analytical services, including formulation, manufacturing, and analytical support for drug products.

2023-Present

edit

During this period, the company expanded operations in Columbia, Missouri.[11] In March 2026, Chris Perkin stepped down as CEO of Altasciences, and was succeeded by Marie-Hélène Raigneau,[12] who joined the company in 2012, and previously held senior leadership roles within the organization, including President in 2025.[13][14]

Acquisitions

edit

Altasciences has acquired and integrated multiple companies:

Facilities and Locations

edit

Altasciences operates nine research and development facilities in the United States and Canada, in addition to an office in the UK. [22][23][24]

The company's nonclinical operations are based in Sacramento, California; Everett, Washington; Columbia, Missouri; and Scranton, Pennsylvania. Clinical pharmacology units are located in Montréal, Quebec; Kansas City, Kansas; and the Los Angeles metropolitan area. Facilities in Laval, Everett, Columbia, and Harleysville also provide bioanalytical and manufacturing services.[23].

Ownership

edit

Altasciences is owned by Novo Holdings A/S, a life science investment company that manages assets on behalf of the Novo Nordisk Foundation and invests in companies across the pharmaceutical, biotechnology, and healthcare industries.[25]

In 2024, Novo Holdings acquired Altasciences from Audax Private Equity.[26][27][28]

Executive leadership

edit

Altasciences is led by Chief Executive Office Marie-Hélène Raigneau[12]. Chris Perkin, who served as Chief Executive Officer from 2010 to 2026, serves as Chairman and Strategic Advisor.[29]

Other executives include:

References

edit
  1. ↑ https://growjo.com/company/Altasciences
  2. ↑ "ALTASCIENCES (LAVAL) - Trouver une ressource - Répertoire des ressources en santé et services sociaux". sante.gouv.qc.ca. Retrieved 2026-05-28.
  3. ↑ "Altasciences". www.citebiotech.com. Retrieved 2026-05-28.
  4. ↑ "Trademarks Document Retrieval Service (TDRS)". www.ic.gc.ca. Retrieved 2026-05-28.
  5. ↑ "Offering Research Services, Preclinical, Early Phase Clinical Studies". www.neoteryx.com. Retrieved 2026-05-28.
  6. ↑ "Altasciences Clinical Research - Company Profile and News". Bloomberg.
  7. ↑ "Introducing Altasciences Company Inc - MediWales". mediwales.com. Retrieved 2026-05-28.
  8. ↑ "Division De Algorithme Informatique · 575 boul. Armand-Frappier, Laval, Quebec H7V 4B3". opengovca.com. Retrieved 2026-05-28.
  9. ↑ "Introducing Altasciences Company Inc - MediWales". mediwales.com. Retrieved 2026-05-28.
  10. 1 2 "Red Jacket Chris Perkin | PharmaVoice". www.pharmavoice.com. Retrieved 2026-05-28.
  11. ↑ "Altasciences Expands Laboratory Capabilities in Columbia". Contract Pharma. 2023-02-15. Retrieved 2026-05-28.
  12. 1 2 jcarlos (2026-03-13). "Altasciences Promotes Marie-Hélène Raigneau to Chief Executive Officer". Women We Admire. Retrieved 2026-05-28.
  13. ↑ "Marie-Helene Raigneau - Board Member at VoxCell BioInnovation". THE ORG. Retrieved 2026-05-28.
  14. ↑ "Marie-Hélène Raigneau - President at Altasciences". THE ORG. Retrieved 2026-05-28.
  15. ↑ "Vince and Associates Clinical Research Joins the Altasciences Group | Applied Clinical Trials Online". www.appliedclinicaltrialsonline.com. 2026-05-28. Retrieved 2026-05-28.
  16. ↑ Keenan, Joseph (2018-08-23). "Altasciences snaps up preclinical testing company for undisclosed price | Fierce Biotech". www.fiercebiotech.com. Retrieved 2026-05-28.
  17. ↑ Adams, Ben (2021-02-23). "Altasciences buys WCCT Global, then gets snapped up itself by a pharma VC | Fierce Biotech". www.fiercebiotech.com. Retrieved 2026-05-28.
  18. ↑ Stanton, Dan (May 26, 2021). "Altasciences: Calvert buy raises status in mid-sized CRO space". Bioxconomy.
  19. ↑ Wright, Tim (January 5, 2022). "Altasciences Acquires Sinclair Research". Contract Pharma.
  20. ↑ Research, Center for Biologics Evaluation and (2026-03-10). "Valley Biosystems - 632553 - 10/14/2022". FDA. Retrieved 2026-05-28.
  21. ↑ Read.
  22. ↑ "Altasciences Locations - Contract Research Map". www.contractresearchmap.com. Retrieved 2026-05-29.
  23. 1 2 "Altasciences | Medhealth Outlook". medhealthoutlook.com. Retrieved 2026-05-29.
  24. ↑ "Altasciences: Support for early drug development in Europe". Swiss Biotech. Retrieved 2026-05-29.
  25. ↑ "Principal Investments Newsletter" (PDF). Novo Holdings. February 2022.
  26. ↑ https://www.audaxprivateequity.com/
  27. ↑ Carvalho-Mitchell, De'Lesia (2017-06-13). "Audax Private Equity Announces the Acquisition of Altasciences Clinical Research". Kilmer Group Corporate. Retrieved 2026-05-29.
  28. ↑ "Audax Private Equity | Audax Private Equity Announces the Acquisition of Altasciences Clinical Research". www.audaxprivateequity.com. Retrieved 2026-05-29.
  29. ↑ Williams, Ellen (2026-02-28). "Altasciences announces Chris Perkin appointed to Board of Directors and Marie-Hélène Raigneau appointed Chief Executive Officer". Bioanalysis Zone. Retrieved 2026-05-29.
  30. ↑ "Steve Mason | Fierce Life Sciences Innovation Awards". fiercelifesciencesinnovationawards.fiercelifesciences.com. Retrieved 2026-06-25.
  31. ↑ Pharma And Lifescience Magazine (2025-10-17). "Altasciences: Empowering Clients with Cohesive, Future-Ready Drug Development". PharmanLifescience Mag. Archived from the original on 2026-02-11. Retrieved 2026-05-29.
  32. ↑ "Altasciences Names Chief Medical Officer". Contract Pharma. 2020-06-09. Retrieved 2026-05-29.
  33. ↑ Adams, Ben (2020-06-09). "Altasciences continues to beef up its exec suite with newly promoted CMO | Fierce Biotech". www.fiercebiotech.com. Retrieved 2026-05-29.
  34. ↑ "Full Article: Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate". www.tandfonline.com. doi:10.1080/03007995.2022.2076474#d1e2002. Retrieved 2026-05-29.
  35. ↑ "The innovative chief administrative officer | News - Concordia University". www.concordia.ca. Retrieved 2026-05-29.
  36. ↑ "Altasciences: How Cathy Konidas is Cultivating People and Driving Progress? | Enterprise Wired". 2026-01-05. Retrieved 2026-05-29.
  37. ↑ "The Heart and Strategy Behind Altasciences' Marketing Evolution". Business Leaders Review: Best Business Magazine and News Online. 2025-07-03. Retrieved 2026-05-29.
  38. ↑ HCP24; PLus 24, Healthcare (2025-03-27). "Julie-Ann Cabana: A Visionary at the Intersection of Science and Strategy". HealthCare Plus24. Retrieved 2026-05-29.{{cite web}}: CS1 maint: numeric names: authors list (link)
    Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Altasciences&oldid=1361130476"